Clinical Trials in Ohio

Showing 3681-3700 of 10,857 trials

COMPLETEDNA26 miles

Performance Evaluation of Different Daily Disposable Silicone Hydrogel Contact Lenses

NCT05805059

The goal of this study is to compare the performance of two daily disposable silicone hydrogel contact lenses.

Myopia

CooperVision, Inc.68 participantsStarted Apr 2023

Ocoee, Florida, United States • Vestal, New York, United States • Granville, Ohio, United States +1 more locations

TERMINATEDPhase 332 miles

Ravulizumab in Thrombotic Microangiopathy Associated With a Trigger

NCT04743804

This study will investigate the efficacy and safety of ravulizumab compared to placebo in adult participants with thrombotic microangiopathy (TMA) associated with a trigger. Participants will be randomized to receive either ravulizumab plus best supportive care or placebo plus best supportive care. The treatment period is 26 weeks followed by a 26-week off-treatment follow-up period.

Thrombotic Microangiopathy

Alexion Pharmaceuticals, Inc.16 participantsStarted Jun 2021

Tucson, Arizona, United States • Orange, California, United States • Washington D.C., District of Columbia, United States +94 more locations

Performance Evaluation of Different Daily Disposable Silicone Hydrogel Contact Lenses

Ravulizumab in Thrombotic Microangiopathy Associated With a Trigger

Find Trials by Condition in Ohio

Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment

Pharmacokinetic Drug-drug Interaction Study of Encorafenib and Binimetinib on Probe Drugs in Patients With BRAF V600-mutant Melanoma or Other Advanced Solid Tumors

Post-Market Study to Assess Outcomes of Patients Treated With AFX System Compared to Other EVAR Devices

Open-Label Extension Study of Trofinetide for Rett Syndrome

A Bioequivalence Study Between the Proposed and Current Talazoparib Capsule Formulation and Food Effect Study for the Proposed Talazoparib Capsule Formulation in Participants With Advanced Solid Tumors

Extension Study of Patidegib Topical Gel, 2% in Subjects With Gorlin Syndrome (Basal Cell Nevus Syndrome)

QUILT-2.017: Phase 1b/2 Study of AMG 479 in Combination With Paclitaxel and Carboplatin for 1st Line Treatment of Advanced Squamous Non-Small Cell Lung Cancer

Promote Weight Loss in Obese Peripheral Artery Disease (PAD) Patients to Prevent Mobility Loss

A Study to Learn About The Study Medicine (PF-07038124) In Patients With Mild To Moderate Atopic Dermatitis Or Mild To Severe Plaque Psoriasis.

Dose De-escalation Study of the PI3k Alpha/Delta Inhibitor, Copanlisib Given in Combination With the Immunotherapeutic Agents, Nivolumab and Rituximab in Patients With Relapsed/Refractory Indolent Lymphoma

Verification of Risk Assignment for Whole Chromosome Using SNP-based NIPT in Vanishing Twin Pregnancies

Phase III Efficacy and Safety Study of Miconazole Oil for Otomycosis

Intravascular Ultrasound-Guided Intervention for Venous Leg Ulcers (IGuideU)

A Study of Semorinemab in Patients With Moderate Alzheimer's Disease

A Study of Anti-PD-L1 Checkpoint Antibody (LY3300054) Alone and in Combination in Participants With Advanced Refractory Solid Tumors

Treatment Efforts Addressing Child Weight Management by Unifying Patients, Parents & Providers

Drug Screening System Method Comparison

Safety, Tolerability, and Pharmacokinetics Study of MK-8189 in Participants With Schizophrenia and Healthy Participants (MK-8189-011)